A visionary company
Transforming ophthalmic care with sustained release therapies
Hydrogel Technology
A platform Engineered for Ocular Innovation
Focused on the future
Developing therapies to enhance the current standard of care
Driven by a vision
Pioneering a new era of drug delivery in ophthalmology
Ocular Therapeutix is a biopharmaceutical company aspiring to be a leader in ophthalmology by leveraging its proprietary hydrogel technology to develop transformational drug products that enhance the patient and provider experience.
Featured Press Release
FDA Accepts DEXTENZA NDA
PDUFA Date: Dec. 28, 2018